[Guidelines for the production, control and regulation of snake antivenom immunoglobulins].
Although frequent and severe, envenomations represent a neglected public health problem in most of the developing countries. Access to antivenoms is poor, mainly in Sub-Saharan Africa, and remains a major concern to World Health Organization (WHO). Since 2007, WHO committed international experts to propose guidelines aiming to improve the manufacture, quality control, registration and use of antivenoms. These guidelines, which will published soon, should promote access to antivenoms, and their use by health services, leading in the short term to a significant decrease of snakebite morbidity and mortality.
Chippaux
Jean-Philippe
JP
Unité de recherche Santé de la mère et de l'enfant en milieu tropical, (IRD UR010), Université Paris Descartes, 4 avenue de l'Observatoire, Paris Cedex 06, France. jean-philippe.chippaux@ird.fr
D017954:Africa South of the Sahara; D000818:Animals; D000997:Antivenins / Q000627:therapeutic use*; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D012909:Snake Bites / Q000276:immunology* / Q000401:mortality; D012911:Snakes; D014944:World Health Organization
D000997:Antivenins; D007136:Immunoglobulins